Presentation is loading. Please wait.

Presentation is loading. Please wait.

South West Home Therapies Conference

Published byMercy Dawson Modified over 6 years ago

Similar presentations

Presentation on theme: "South West Home Therapies Conference"— Presentation transcript:

1 South West Home Therapies Conference
Dr Preetham Boddana Consultant Nephrologist GHNHSFT 16th March 2016

2 Agenda Welcome and Working together Key features of the programme
Reflection and take home messages

3 SW Renal Units

4 UK Renal Registry 17th Annual Report
Figure 2.6. Treatment modality in prevalent RRT patients on 31/12/2013 UK Renal Registry 17th Annual Report

5 UK Renal Registry 17th Annual Report
Figure 2.8. Percentage of prevalent haemodialysis patients treated with satellite or home haemodialysis by centre on 31/12/2012 UK Renal Registry 17th Annual Report

6 Take home messages

Download ppt "South West Home Therapies Conference"

Similar presentations

UK Renal Registry 13th Annual Report Figure 12.1: Median height z-scores for transplant patients in 2009.

UK Renal Registry 13th Annual Report Figure 12.1: Median height z-scores for transplant patients in 2009.
The future of haemodialysis in the UK RCP advanced medicine 2013 Cormac Breen Consultant Nephrologist Guy's and St Thomas' Hospitals London.

The future of haemodialysis in the UK RCP advanced medicine 2013 Cormac Breen Consultant Nephrologist Guy's and St Thomas' Hospitals London.
UK Renal Registry 17th Annual Report Figure 10.1. Data completeness for key variables, stratified by first modality DOB = date of birth; PRD = primary.

UK Renal Registry 17th Annual Report Figure Data completeness for key variables, stratified by first modality DOB = date of birth; PRD = primary.
UK Renal Registry 15th Annual Report Figure 5.26. One year death rate per 1,000 patient years by UK country and age group for prevalent dialysis.

UK Renal Registry 15th Annual Report Figure One year death rate per 1,000 patient years by UK country and age group for prevalent dialysis.
UK Renal Registry 16th Annual Report Figure 5.1. Flow chart showing number of patients included in the various analyses.

UK Renal Registry 16th Annual Report Figure 5.1. Flow chart showing number of patients included in the various analyses.
UK Renal Registry 16th Annual Report Figure 8.1. Trend in 1 year after 90 day incident patient survival by first modality, 2005–2011 cohort (adjusted to.

UK Renal Registry 16th Annual Report Figure 8.1. Trend in 1 year after 90 day incident patient survival by first modality, 2005–2011 cohort (adjusted to.
Summary of the 2012 ERA-EDTA Registry Annual Report Amsterdam, the Netherlands, 2014.

Summary of the 2012 ERA-EDTA Registry Annual Report Amsterdam, the Netherlands, 2014.
UK Renal Registry 17th Annual Report Figure 9.1. Median height z-scores for transplant patients

UK Renal Registry 17th Annual Report Figure 9.1. Median height z-scores for transplant patients
UK Renal Registry 16th Annual Report Figure 10.1. Median haemoglobin for incident dialysis patients at start of dialysis treatment in 2012.

UK Renal Registry 16th Annual Report Figure Median haemoglobin for incident dialysis patients at start of dialysis treatment in 2012.
UK Renal Registry 14th Annual Report Figure 8.1. Median haemoglobin for incident dialysis patients at start of dialysis treatment in 2010.

UK Renal Registry 14th Annual Report Figure 8.1. Median haemoglobin for incident dialysis patients at start of dialysis treatment in 2010.
UK Renal Registry 17th Annual Report Figure 8.1. Percentage of haemodialysis patients with phosphate within the range specified by the RA clinical audit.

UK Renal Registry 17th Annual Report Figure 8.1. Percentage of haemodialysis patients with phosphate within the range specified by the RA clinical audit.
UK Renal Registry 17th Annual Report Figure 3.1. Transplant prevalence rate per million population by age and gender on 31/12/2013.

UK Renal Registry 17th Annual Report Figure 3.1. Transplant prevalence rate per million population by age and gender on 31/12/2013.
UKRR Annual Informatics Meeting, September 2013 Highlights from the 15 th Annual Report Rishi Pruthi Research Fellow UK Renal Registry.

UKRR Annual Informatics Meeting, September 2013 Highlights from the 15 th Annual Report Rishi Pruthi Research Fellow UK Renal Registry.
UK Renal Registry 14th Annual Report Figure 3.1. Transplant prevalence rate per million population by age and gender on 31/12/2010.

UK Renal Registry 14th Annual Report Figure 3.1. Transplant prevalence rate per million population by age and gender on 31/12/2010.
UK Renal Registry 17th Annual Report Figure 11.1. Percentage of patients waitlisted for a kidney transplant by renal centre, prior to or within two years.

UK Renal Registry 17th Annual Report Figure Percentage of patients waitlisted for a kidney transplant by renal centre, prior to or within two years.
UK Renal Registry 17th Annual Report Figure 2.1. Prevalence rates per million population by age group and UK country on 31/12/2013.

UK Renal Registry 17th Annual Report Figure 2.1. Prevalence rates per million population by age group and UK country on 31/12/2013.
UK Renal Registry 10th Annual Report 2007 Fig 3.1 Incident rates in the countries of the UK: 1990-2006.

UK Renal Registry 10th Annual Report 2007 Fig 3.1 Incident rates in the countries of the UK:
UK Renal Registry 14th Annual Report Figure 10.1. Summary of BP achievements.

UK Renal Registry 14th Annual Report Figure Summary of BP achievements.
UK Renal Registry 17th Annual Report Figure 1.1. RRT incidence rates in the countries of the UK 1990–2013.

UK Renal Registry 17th Annual Report Figure 1.1. RRT incidence rates in the countries of the UK 1990–2013.
UK Renal Registry 10th Annual Report 2007 Fig 8.1 Median haemoglobin for incident dialysis patients at start of dialysis treatment.

UK Renal Registry 10th Annual Report 2007 Fig 8.1 Median haemoglobin for incident dialysis patients at start of dialysis treatment.

Similar presentations

Ads by Google